Unknown PHASE2 INTERVENTIONAL 2-arm NCT06075381

Pulmonary Expansion Device in Tracheostomized Patients Therapies in Tracheostomized Patients (PEDTRAQ)

Safety and Efficacy of the Pulmonary Expansion Device (PED): A Novel Postoperative Pulmonary Reexpansion Strategy Using Negative Pressure Generation for the Management of Tracheostomized Patients - Phase 2 Study

Sponsor: Fundacion Clinica Valle del Lili

Conditions Postoperative Care Postoperative Complications Rehabilitation

Interventions Conventional management Pulmonary Expansion Device (PED)

Updated 4 times since 2023 Last updated: Oct 3, 2023 Started: Feb 29, 2024 Primary completion: Jun 30, 2025 Completion: Nov 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Postoperative Care and Postoperative Complications and is currently ongoing. Fundacion Clinica Valle del Lili leads this study, which shows 4 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Jan 2026 — Present [monthly]

Unknown PHASE2

Status: Not Yet Recruiting → Unknown
Sep 2024 — Jan 2026 [monthly]

Not Yet Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE2
Nov 2023 — Jul 2024 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundacion Clinica Valle del Lili

Data source: Fundacion Clinica Valle del Lili

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.